Search Results - "SVENBERG, P"

A prospective randomized toxicity study to compare reduced‐intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation by Ringdén, O., Erkers, T., Aschan, J., Garming‐Legert, K., Blanc, K., Hägglund, H., Omazic, B., Svenberg, P., Dahllöf, G., Mattsson, J., Ljungman, P., Remberger, M.

“…Background To our knowledge, no randomized toxicity studies have been conducted to compare myeloablative conditioning (MAC) and reduced‐intensity conditioning…”
Get full text

Allogeneic hematopoietic SCT in patients with non-malignant diseases, and importance of chimerism by Svenberg, P, Mattsson, J, Ringdén, O, Uzunel, M

“…In this retrospective study, we evaluated the chimerism status and outcome in 58 patients (64 transplants) with non-malignant diseases. Reduced intensity…”
Get full text

Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases by RINGDEN, O, REMBERGER, M, BARKHOLT, L, WINIARSKI, J, LJUNGMAN, P, MATTSSON, J, SVENBERG, P, SVAHN, B.-M, DAHLLÖF, G, GUSTAFSSON, B, HASSAN, Z, OMAZIC, B, UZUNEL, M, ASCHAN, J

“…Fludarabine-based conditioning (FBC) was given to 24 patients and conventional myeloablative conditioning (MC) to 33 patients, most children, before…”
Get full text

Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia by ZETTERQUIST, H, MATTSSON, J, UZUNEL, M, NÄSMAN-BJÖRK, I, SVENBERG, P, TAMMIK, L, BAYAT, G, WINIARSKI, J, RINGDEN, O

“…One of the major problems after allogeneic bone marrow transplantation (BMT) is a high frequency of leukemia relapse. We have prospectively studied the…”
Get full text

Myeloablative conditioning for hematopoietic stem-cell transplantation in patients with non-malignant diseases by Ringdén, O, Svenberg, P, Le Blanc, K, Mattsson, J, Remberger, M

Get full text

Temporal changes in incidence of relapse and outcome after relapse of childhood acute lymphoblastic leukemia over three decades; a Nordic population-based cohort study by Jensen, Karen Schow, Oskarsson, Trausti, Lähteenmäki, Päivi M., Flaegstad, Trond, Jónsson, Ólafur Gísli, Svenberg, Petter, Schmiegelow, Kjeld, Heyman, Mats, Norén-Nyström, Ulrika, Schrøder, Henrik, Albertsen, Birgitte Klug

“…Relapse remains the main obstacle to curing childhood acute lymphoblastic leukemia (ALL). The aims of this study were to compare incidence of relapse,…”
Get full text

The Importance of Graft Cell Composition to Outcome After Allogeneic Stem Cell Transplantation by Svenberg, P, Ringden, O, Uzunel, M

Get full text

The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease by Svenberg, Petter, Wang, Tengyu, Uhlin, Michael, Watz, Emma, Remberger, Mats, Ringden, Olle, Mattsson, Jonas, Uzunel, Mehmet

“…Background Graft‐versus‐host disease (GVHD) and relapse remain majobstacles ftreatment success in allogeneic hematopoietic stem cell transplantation (HSCT). In…”
Get full text

Improved overall survival for pediatric patients undergoing allogeneic hematopoietic stem cell transplantation - A comparison of the last two decades by Svenberg, Petter, Remberger, Mats, Uzunel, Mehmet, Mattsson, Jonas, Gustafsson, Britt, Fjaertoft, Gustav, Sundin, Mikael, Winiarski, Jacek, Ringdén, Olle

“…Pediatric protocols for allogeneic hematopoietic SCT have been altered during the last two decades. To compare the outcomes in children (<18 yr old), who…”
Get full text

Social capital as a theory of change for young people’s health:a scoping review preliminary findings by Morgan, A, Nygren, J, Nyholm, M, Svenberg, P

Get full text

Ten Years Experience of Home-Care During the Neutropenic Phase After Allogeneic Hematopoietic Stem Cell Transplantation by Ringden, O, Remberger, M, Wikstrom, M, Holmberg, K, Eriksson, B, Fransson, K, Milovsavljevic, R, Omazic, B, Svenberg, P, Mattsson, J, Svahn, B.-M

Get full text

A Prospective Randomized Study Comparing Reduced-Intensity Conditioning and Myeloablative Conditioning in Patients with Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation by Ringden, O, Erkers, T, Aschan, J, Le Blanc, K, Hagglund, H, Omazic, B, Svenberg, P, Ljungman, P, Mattsson, J, Remberger, M

Get full text

Case Report: Whole genome sequencing identifies CCDC88C as a novel JAK2 fusion partner in pediatric T-cell acute lymphoblastic leukemia by Krstic, Aleksandra, Rezayee, Fatemah, Saft, Leonie, Hammarsjö, Anna, Svenberg, Petter, Barbany, Gisela

“…In the present report, we applied whole genome sequencing (WGS) to genetically characterize a case of pediatric T-cell acute lymphoblastic leukemia (ALL)…”
Get full text

Sensitive and quantitative chimerism analysis in AML patients with real-time PCR by Svenberg, P., Uzunel, M., Ringdén, O.

Get full text

Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib by Guan, Jikui, Fransson, Susanne, Siaw, Joachim Tetteh, Treis, Diana, Van den Eynden, Jimmy, Chand, Damini, Umapathy, Ganesh, Ruuth, Kristina, Svenberg, Petter, Wessman, Sandra, Shamikh, Alia, Jacobsson, Hans, Gordon, Lena, Stenman, Jakob, Svensson, Pär-Johan, Hansson, Magnus, Larsson, Erik, Martinsson, Tommy, Palmer, Ruth H, Kogner, Per, Hallberg, Bengt

“…Tumors with anaplastic lymphoma kinase (ALK) fusion rearrangements, including non-small-cell lung cancer and anaplastic large cell lymphoma, are highly…”
Get full text

Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma o the ALK inhibitor ceritinib by Guan, Jikui, Fransson, Susanne, Siaw, Joachim Tetteh, Treis, Diana, Van den Eynden, Jimmy, Chand, Damini, Umapathy, Ganesh, Ruuth, Kristina, Svenberg, Petter, Wessman, Sandra, Shamikh, Alia, Jacobsson, Hans, Gordon, Lena, Stenman, Jakob, Svensson, Pär-Johan, Hansson, Magnus, Larsson, Erik, Martinsson, Tommy, Palmer, Ruth H., Kogner, Per, Hallberg, Bengt

“…Tumors with anaplastic lymphoma kinase (ALK) fusion rearrangements, including non-small-cell lung cancer and anaplastic large cell lymphoma, are highly…”
Get full text

Factors With an Impact on Chimerism Development and Long-Term Survival After Umbilical Cord Blood Transplantation by BERGLUND, Sofia, LE BLANC, Katarina, MATTSSON, Jonas, REMBERGER, Mats, GERTOW, Jens, UZUNEL, Mehmet, SVENBERG, Petter, WINIARSKI, Jacek, LJUNGMAN, Per, RINGDEN, Olle, UHLIN, Michael

“…Umbilical cord blood transplantation (UCBT) is increasingly used and produces similar results to matched unrelated donor transplantation. We performed a…”
Get full text

The importance of graft cell composition to outcome after allogeneic stem cell transplantation by Svenberg, P, Ringden, O, Uzunel, M

“…Background: Stem cell dose has been shown to be important for outcome in patients who undergo stem cell transplantation (SCT). Grafts may contain varying…”
Get full text

Allogeneic hematopoietic stem cell transplantation for inherited disorders: Experience in a single-center by Mattsson, J., Remberger, M., Svahn, B.-M., Svenberg, P., Winiarski, J., Ringden, O.

Get full text

Predictive value of cell-lineage chimerism analysis for relapse in Acute Myeloid Leukemia by Uzunel, M, Svenberg, P, Hauzenberger, D, Mattsson, I

Get full text